Position in ATEC
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$7,572
-$7,071 QoQ
Shares Held
696
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
13 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ATEC Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026QUADRANT CAPITAL GROUP LLC holds $18,691,297 across 17 Medical Devices names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
36,687 | $3,328,978 | |
| 2 | BSX |
Boston Scientific Corp
|
67,683 | $2,888,710 | |
| 3 | SYK |
Stryker Corp
|
7,715 | $2,428,990 | |
| 4 | EW |
Edwards Lifesciences Corp
|
18,811 | $1,701,643 | |
| 5 | PODD |
Insulet Corp
|
7,936 | $1,208,256 | |
| 6 | SNN |
Smith & Nephew PLC
|
41,174 | $1,186,222 | |
| 7 | PEN |
Penumbra Inc
|
3,094 | $976,930 | |
| 8 | GKOS |
GLAUKOS Corp
|
6,879 | $961,409 |
All Filings in ATEC
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,572 | 696 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $14,643 | 696 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $11,879 | 817 | Shares | Sole | 2025-11-13 | |
| 2025-03-31 | $7,757 | 765 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $7,022 | 765 | Shares | Sole | 2025-02-13 | |
| 2024-06-30 | $2,340 | 224 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $4,702 | 341 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $4,261 | 282 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $8,728 | 673 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,344 | 186 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $2,901 | 186 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,297 | 186 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $585 | 67 | Shares | Sole | 2022-11-10 | |
| No filing history on record for this holder in this stock. | ||||||